Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Milestone Scientific (MLSS) Cash from Financing Activities (2016 - 2025)

Milestone Scientific's Cash from Financing Activities history spans 14 years, with the latest figure at -$4556.0 for Q3 2025.

  • For Q3 2025, Cash from Financing Activities fell 75.57% year-over-year to -$4556.0; the TTM value through Sep 2025 reached $787226.0, down 71.92%, while the annual FY2024 figure was $233771.0, 90.87% down from the prior year.
  • Cash from Financing Activities for Q3 2025 was -$4556.0 at Milestone Scientific, down from $796583.0 in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $3.7 million in Q1 2021 and bottomed at -$4556.0 in Q3 2025.
  • The 5-year median for Cash from Financing Activities is -$2162.0 (2023), against an average of $429736.5.
  • The largest annual shift saw Cash from Financing Activities crashed 102.87% in 2022 before it skyrocketed 124843.49% in 2023.
  • A 5-year view of Cash from Financing Activities shows it stood at $673943.0 in 2021, then tumbled by 100.31% to -$2058.0 in 2022, then surged by 124843.49% to $2.6 million in 2023, then tumbled by 100.1% to -$2523.0 in 2024, then crashed by 80.58% to -$4556.0 in 2025.
  • Per Business Quant, the three most recent readings for MLSS's Cash from Financing Activities are -$4556.0 (Q3 2025), $796583.0 (Q2 2025), and -$2278.0 (Q1 2025).